The global mouth ulcers treatment market was valued at 1,655.00 million in 2020, and is projected to reach $2,375.7 million by 2030, registering a CAGR of 3.8% from 2021 to 2030. Mouth ulcers are painful breaks and sores appearing in the mucous membrane of the oral cavity of the mouth's soft tissues, including the lips, cheeks, gums, tongue, floor, and roof. It can also appear on the esophagus. They are usually pale or yellow painful sores with a red outer ring. Mouth sores, including canker sores, are usually a minor irritation that lasts only a week or two. They are extremely common, occurring in association with a wide range of diseases and through a variety of mechanisms, but there is usually no serious underlying cause. However, in some cases, they can imply mouth cancer or a virus infection.
Canker sores are caused by an underlying auto-immune condition called aphthous stomatitis. In addition, certain hormonal changes, such as increased or reduced level of certain hormones, can be another cause of canker sores (aphthous ulcers) on the tongue, mouth or lips. If a person has aphtous stomatitis, he will most likely have canker sores on a frequent basis. It is estimated that up to 20% of persons in the UK are affected by this. Mouth ulcers and canker sores are very identical and may be controlled and treated in the same way. In 2019, according to National Health Portal (NHP) of India, aphthous stomatitis or canker sores affect approximately 20% of the general population and they are slightly more common in girls and women.
The growth of the global mouth ulcers treatment market is majorly driven by higher prevalence of mouth ulcers due to increased use of chemicals in food, including citrus or acidic fruits and vegetables (such as lemons, oranges, pineapples, apples, figs, tomatoes, strawberries), oral products, such as toothpaste, the rise in anxiety and stress, and tobacco use. Furthermore, due to increasing oral hygiene and mouth infection treatment awareness, rising adoption of pharmaceuticals as a treatment option and a significant rise in the count of geriatric population also contribute to the market growth.
Smoking cessation though beneficial for health, mouth ulcers are its unfortunate side effect. According to Centers for Disease Control and Prevention (CDC) in 2019, 57.8% of youth (middle and high school students) who currently used tobacco products (3.3 million) reported that they were seriously thinking about quitting the use of all tobacco products. Thus, this gave rise to increased cases of mouth ulcers and an opportunity for the companies to invest in the mouth ulcers treatment market.
According to World Health Organization (WHO) in 2021, tobacco kills more than 8 million people each year and more than 7 million of those deaths are a result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Over 80% of the world's 1.3 billion tobacco users live in low and middle income countries. Thus, increasing the occurrence of mouth ulcers and further driving the market significantly.
The American Academy of Oral Medicine (AAOM) affirmed that patients with oral lichen planus (inflammatory condition that affects mucous membranes inside your mouth) has an increased risk of developing oral cancer and requires careful management and monitoring by appropriately trained clinicians. Noma is a severe gangrenous disease that affects the mouth and face and primarily affects children aged 2 to 6 years who are malnourished, infected with infectious disease, living in extreme poverty with poor oral hygiene, and/or have weakened immune systems. It begins as a soft tissue lesion (a sore) of the gums, deep within the mouth. Recurrent aphthous ulcers are the most common oral mucosal disease in North America. They affect 20% of the population, with the incidence rising to more than 50% in certain groups of students in professional schools. According to WHO in March 2020, oral diseases pose a major health burden for many countries and affect people throughout their lifetime, causing pain, discomfort, disfigurement and even death. It is estimated that oral diseases affect nearly 3.5 billion people.
In addition, increased consciousness for dental and oral hygiene, availability of different treatments, rapid healing and easy to use products for treating ulcers are the major factors that drive the global mouth ulcers treatment market. Moreover, the emergence of innovative products, technical advancements in the field of dental care, and increasing use of pharmaceuticals for oral treatment are expected to enhance the demand for mouth ulcers treatment. Thus, advancements in technology in the healthcare sector and rise in prevalence of mouth ulcers due to inclination towards healthy lifestyle are expected to propel the growth of the market.
On the contrary, presence of substitute traditional treatments, limited accessibility to pharmaceuticals in developing countries, and side effects associated with the use of mouth ulcer treatment products are curtailing the market growth. Conversely, the rise in adoption of affordable treatments in developing as well as under developed countries, by increasing government initiatives, reduced side effects, and self-awareness for healthy lifestyle accordingly encourages many key players to enter into the competition, thus creating a lucrative growth opportunity for the mouth ulcers treatment market.
The global mouth ulcers treatment market is segmented on the basis of drug class, formulation type, indication, and region. On the basis of drug class, the market is categorized into analgesics and corticosteroids, antihistamine, antimicrobial, and anesthetic. By formulation type, the market is divided into sprays, mouthwash, gels, and lozenges. By indication, the market is classified into aphthous stomatitis, oral lichen planus, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global mouth ulcers treatment market include Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co, Inc., Colgate Palmolive Company, Dr. Reddy’s, GlaxoSmithKline, plc., Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, and 3M.
Canker sores are caused by an underlying auto-immune condition called aphthous stomatitis. In addition, certain hormonal changes, such as increased or reduced level of certain hormones, can be another cause of canker sores (aphthous ulcers) on the tongue, mouth or lips. If a person has aphtous stomatitis, he will most likely have canker sores on a frequent basis. It is estimated that up to 20% of persons in the UK are affected by this. Mouth ulcers and canker sores are very identical and may be controlled and treated in the same way. In 2019, according to National Health Portal (NHP) of India, aphthous stomatitis or canker sores affect approximately 20% of the general population and they are slightly more common in girls and women.
The growth of the global mouth ulcers treatment market is majorly driven by higher prevalence of mouth ulcers due to increased use of chemicals in food, including citrus or acidic fruits and vegetables (such as lemons, oranges, pineapples, apples, figs, tomatoes, strawberries), oral products, such as toothpaste, the rise in anxiety and stress, and tobacco use. Furthermore, due to increasing oral hygiene and mouth infection treatment awareness, rising adoption of pharmaceuticals as a treatment option and a significant rise in the count of geriatric population also contribute to the market growth.
Smoking cessation though beneficial for health, mouth ulcers are its unfortunate side effect. According to Centers for Disease Control and Prevention (CDC) in 2019, 57.8% of youth (middle and high school students) who currently used tobacco products (3.3 million) reported that they were seriously thinking about quitting the use of all tobacco products. Thus, this gave rise to increased cases of mouth ulcers and an opportunity for the companies to invest in the mouth ulcers treatment market.
According to World Health Organization (WHO) in 2021, tobacco kills more than 8 million people each year and more than 7 million of those deaths are a result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Over 80% of the world's 1.3 billion tobacco users live in low and middle income countries. Thus, increasing the occurrence of mouth ulcers and further driving the market significantly.
The American Academy of Oral Medicine (AAOM) affirmed that patients with oral lichen planus (inflammatory condition that affects mucous membranes inside your mouth) has an increased risk of developing oral cancer and requires careful management and monitoring by appropriately trained clinicians. Noma is a severe gangrenous disease that affects the mouth and face and primarily affects children aged 2 to 6 years who are malnourished, infected with infectious disease, living in extreme poverty with poor oral hygiene, and/or have weakened immune systems. It begins as a soft tissue lesion (a sore) of the gums, deep within the mouth. Recurrent aphthous ulcers are the most common oral mucosal disease in North America. They affect 20% of the population, with the incidence rising to more than 50% in certain groups of students in professional schools. According to WHO in March 2020, oral diseases pose a major health burden for many countries and affect people throughout their lifetime, causing pain, discomfort, disfigurement and even death. It is estimated that oral diseases affect nearly 3.5 billion people.
In addition, increased consciousness for dental and oral hygiene, availability of different treatments, rapid healing and easy to use products for treating ulcers are the major factors that drive the global mouth ulcers treatment market. Moreover, the emergence of innovative products, technical advancements in the field of dental care, and increasing use of pharmaceuticals for oral treatment are expected to enhance the demand for mouth ulcers treatment. Thus, advancements in technology in the healthcare sector and rise in prevalence of mouth ulcers due to inclination towards healthy lifestyle are expected to propel the growth of the market.
On the contrary, presence of substitute traditional treatments, limited accessibility to pharmaceuticals in developing countries, and side effects associated with the use of mouth ulcer treatment products are curtailing the market growth. Conversely, the rise in adoption of affordable treatments in developing as well as under developed countries, by increasing government initiatives, reduced side effects, and self-awareness for healthy lifestyle accordingly encourages many key players to enter into the competition, thus creating a lucrative growth opportunity for the mouth ulcers treatment market.
The global mouth ulcers treatment market is segmented on the basis of drug class, formulation type, indication, and region. On the basis of drug class, the market is categorized into analgesics and corticosteroids, antihistamine, antimicrobial, and anesthetic. By formulation type, the market is divided into sprays, mouthwash, gels, and lozenges. By indication, the market is classified into aphthous stomatitis, oral lichen planus, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global mouth ulcers treatment market include Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co, Inc., Colgate Palmolive Company, Dr. Reddy’s, GlaxoSmithKline, plc., Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, and 3M.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global mouth ulcers treatment market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region-& country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Drug Class
- Analgesics and corticosteroids
- Antihistamine
- Antimicrobial
- Anesthetic
By Formulation
- Sprays
- Mouthwash
- Gels
- Lozenges
By Indication
- Aphthous Stomatitis
- Oral Lichen Planus
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
KEY MARKET PLAYERS
- Blistex Inc.
- Bristol-Myers Squibb Company
- Church & Dwight Co, Inc.,
- Colgate Palmolive Company,
- Dr. Reddy’s Laboratories Ltd.
- GlaxoSmithKline, plc.,
- Patterson Companies, Inc.,
- Pfizer Inc.,
- Prince Care Pharma Private Limited
- 3M
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS
CHAPTER 5: MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE
CHAPTER 6: MOUTH ULCERS TREATMENT MARKET, BY INDICATION
CHAPTER 7: MOUTH ULCERS TREATMENT MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 245 |
| Published | September 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 1636.13 million |
| Forecasted Market Value ( USD | $ 2375.7 million |
| Regions Covered | Global |
